Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 1 of 1 for:    NCT01826487
Previous Study | Return to List | Next Study

Phase 3 Study of Ataluren in Patients With Nonsense Mutation Duchenne Muscular Dystrophy (ACT DMD)

This study has been completed.
Information provided by (Responsible Party):
PTC Therapeutics Identifier:
First received: March 26, 2013
Last updated: August 2, 2016
Last verified: October 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2015
  Primary Completion Date: August 2015 (Final data collection date for primary outcome measure)